Your browser doesn't support javascript.
loading
Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trial.
Torelli, Giovanni Fernando; Chiaretti, Sabina; Peragine, Nadia; Barberi, Walter; Santodonato, Laura; D'Agostino, Giuseppina; Abruzzese, Elisabetta; Del Principe, Maria Ilaria; Mancino, Alessandra; Matarazzo, Mabel; Bafti, Mahnaz Shafii; Mancini, Marco; Messina, Monica; Castiello, Luciano; Guarini, Anna; Foà, Robin.
Afiliación
  • Torelli GF; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Chiaretti S; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Peragine N; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Barberi W; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Santodonato L; FaBioCell Cell Factory, Istituto Superiore di Sanità, Rome, Italy.
  • D'Agostino G; FaBioCell Cell Factory, Istituto Superiore di Sanità, Rome, Italy.
  • Abruzzese E; Hematology, Sant'Eugenio Hospital, ASL Roma2, Tor Vergata University, Rome, Italy.
  • Del Principe MI; Hematology, Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Mancino A; Data Center, Fondazione GIMEMA Onlus, Rome, Italy.
  • Matarazzo M; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Bafti MS; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Mancini M; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Messina M; Data Center, Fondazione GIMEMA Onlus, Rome, Italy.
  • Castiello L; FaBioCell Cell Factory, Istituto Superiore di Sanità, Rome, Italy.
  • Guarini A; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Foà R; Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy.
Am J Hematol ; 97(6): E204-E207, 2022 06 01.
Article en En | MEDLINE | ID: mdl-35315128
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Humans Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Humans Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Italia